Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

DELRAY BEACH, Fla., Oct. 28, 2025 /PRNewswire/ -- The global Cell-free Protein Synthesis Market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a ...

The global Cell-free Protein Synthesis Market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle vaccines that mimic viruses at the molecular level, offering a powerful new ...

Ebihara Takashi has been the chief operating officer of GeneFrontier (GFC) since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. He earned a ...

For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such as reprogramming a stem cell into a neuron or generating a protein that ...